首页> 外文期刊>International journal of infectious diseases : >Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease
【24h】

Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease

机译:英夫利昔单抗和霉酚酸酯治疗贝塞特病患者的隐球菌性脑膜炎

获取原文
           

摘要

A 46-year-old Caucasian male was admitted in June 2007 for a recent history of headaches and fever. He had been treated for Beh?et's disease for the past seven years, with recurrent oral aphtosis, diffuse arthralgias and severe uveitis. Unusual severe bilateral uveitis prompted us to give oral corticosteroids for 30 months, infliximab for 18 months and mycophenolate mofetil (2?g/day) for 14 months. Infliximab was started in January 2006 at a dose of 3?mg/kg/infusion (250?mg) and then 5?mg/kg/infusion (400?mg) in January 2007.
机译:2007年6月,一名46岁的白人男性因近期头痛和发烧史而入院。在过去的七年中,他因反复发作的口腔萎缩症,弥漫性关节痛和严重的葡萄膜炎而接受了贝希特氏病的治疗。异常的严重双侧葡萄膜炎促使我们口服皮质类固醇30个月,英夫利昔单抗18个月,霉酚酸酯(2 µg /天)连续14个月。英夫利昔单抗于2006年1月开始,剂量为3?mg / kg /输液(250?mg),然后于2007年1月以5?mg / kg /输液(400?mg)开始。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号